 data, for patients with poor tibial or pedal runoff, OPAR with GSV
is considered preferential to EPAR for good-risk patients. High-risk patients, deÔ¨Åned as those with a high
cardiovascular risk or adverse anatomic criteria such as
severe venous stasis or lymphedema, pose a challenge
because the natural history of PAA is known only from
purely retrospective data. As such, for patients with a
poor life expectancy